Kolon Life Science Launches Osteoarthritis Drug Invossa in Korea
![T-cell graphic](https://www.biolifesolutions.com/wp-content/uploads/2023/01/Cryopreservation-cell.jpg)
Kolon Life Science Launches Osteoarthritis Drug Invossa in Korea A huge congratulations to BioLife customer TissueGene / Kolon Life Science on their first patient use of CryoStor – powered Invossa, a novel cell-mediated therapy for degenerative arthritis. Invossa is the world’s first gene therapy for treating osteoarthritis of the knee, in which the cartilage that cushions […]